268 related articles for article (PubMed ID: 28327075)
1. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.
Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D
Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075
[TBL] [Abstract][Full Text] [Related]
2. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
3. Herceptin-decorated paclitaxel-loaded poly(lactide-
Zhong S; Ling Z; Zhou Z; He J; Ran H; Wang Z; Zhang Q; Song W; Zhang Y; Luo J
Pharm Dev Technol; 2020 Apr; 25(4):454-463. PubMed ID: 31873051
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
5. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer.
Lan M; Zhu L; Wang Y; Shen D; Fang K; Liu Y; Peng Y; Qiao B; Guo Y
J Nanobiotechnology; 2020 Sep; 18(1):121. PubMed ID: 32883330
[TBL] [Abstract][Full Text] [Related]
8. SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy.
Huang HY; Hu SH; Hung SY; Chiang CS; Liu HL; Chiu TL; Lai HY; Chen YY; Chen SY
J Control Release; 2013 Nov; 172(1):118-127. PubMed ID: 23933522
[TBL] [Abstract][Full Text] [Related]
9. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodalimaging contrast agent.
Luo B; Zhang H; Liu X; Rao R; Wu Y; Liu W
Biomed Mater Eng; 2015; 26 Suppl 1():S911-6. PubMed ID: 26406092
[TBL] [Abstract][Full Text] [Related]
10. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract][Full Text] [Related]
11. Highly versatile SPION encapsulated PLGA nanoparticles as photothermal ablators of cancer cells and as multimodal imaging agents.
Sivakumar B; Aswathy RG; Romero-Aburto R; Mitcham T; Mitchel KA; Nagaoka Y; Bouchard RR; Ajayan PM; Maekawa T; Sakthikumar DN
Biomater Sci; 2017 Feb; 5(3):432-443. PubMed ID: 28059418
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
[TBL] [Abstract][Full Text] [Related]
13. A novel bubble-forming material for preparing hydrophobic-agent-loaded bubbles with theranostic functionality.
Yang PS; Tung FI; Chen HP; Liu TY; Lin YY
Acta Biomater; 2014 Aug; 10(8):3762-74. PubMed ID: 24830551
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-Loaded Magnetic Nanoparticles: Synthesis, Characterization, and Application in Targeting.
Tian J; Yan C; Liu K; Tao J; Guo Z; Liu J; Zhang Y; Xiong F; Gu N
J Pharm Sci; 2017 Aug; 106(8):2115-2122. PubMed ID: 28456728
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of paclitaxel to iron oxide nanoparticles for tumor imaging and therapy.
Liu D; Wu W; Chen X; Wen S; Zhang X; Ding Q; Teng G; Gu N
Nanoscale; 2012 Apr; 4(7):2306-10. PubMed ID: 22362270
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Characterization of PLGA-based Magnetic Polymer Nanoparticles for Targeting Pancreatic Adenocarcinoma.
Lu L; Jie L; Zhou Y; Zhang J; Feng T; Zhu Y; Chen T; Zhu X; Ji J; Wang Z
Curr Pharm Des; 2023; 29(9):686-696. PubMed ID: 36967466
[TBL] [Abstract][Full Text] [Related]
18. Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell lines.
He Y; Song W; Lei J; Li Z; Cao J; Huang S; Meng J; Xu H; Jin Z; Xue H
Acta Radiol; 2012 Nov; 53(9):1049-58. PubMed ID: 23012484
[TBL] [Abstract][Full Text] [Related]
19. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
[TBL] [Abstract][Full Text] [Related]
20. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
